Millennium Management’s Transition Therapeutics TTHI Stock Holding History
Bought
Maintained
Sold
Other funds holding TTHI
SM
Millennium Management's TTHI Position: Q2 2015 in Review
Millennium Management sold out of Transition Therapeutics (TTHI) in Q2 2015, closing a stake of 35,000 shares — an estimated $239K sold.
Millennium Management first reported a position in TTHI in Q1 2015 and held it in 1 quarter. The position peaked at $239K in Q1 2015. 30 funds tracked by Wall St. Rank hold TTHI as of Q2 2015.
- Millennium Management reported no remaining Transition Therapeutics position as of Q2 2015 after selling out during the quarter.
- Millennium Management sold 35,000 Transition Therapeutics shares in Q2 2015, an estimated $239K.
- Millennium Management first reported a position in Transition Therapeutics in Q1 2015 and held it in 1 quarter.
- Millennium Management's Transition Therapeutics position peaked at $239K in Q1 2015.
- 30 funds tracked by Wall St. Rank held Transition Therapeutics as of Q2 2015.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.